Significance of anti-neutrophil cytoplasmic antibodies in systemic sclerosis

Abstract Background Up to 12% of patients with systemic sclerosis (SSc) have anti-neutrophil cytoplasmic antibodies (ANCA). However, the majority of these patients do not manifest ANCA-associated vasculitis (AAV) and the significance of ANCA in these patients is unclear. The aim of this study is to...

Full description

Bibliographic Details
Published in:	Arthritis Research & Therapy
Main Authors:	Jayne Moxey, Molla Huq, Susanna Proudman, Joanne Sahhar, Gene-Siew Ngian, Jenny Walker, Gemma Strickland, Michelle Wilson, Laura Ross, Gabor Major, Janet Roddy, Wendy Stevens, Mandana Nikpour
Format:	Article
Language:	English
Published:	BMC 2019-02-01
Subjects:	Anti-neutrophil cytoplasmic antibodies (ANCA) Systemic sclerosis (SSc) ANCA-associated vasculitis Myeloperoxidase (MPO) Proteinase-3 (PR3)
Online Access:	http://link.springer.com/article/10.1186/s13075-019-1839-5

Internet

http://link.springer.com/article/10.1186/s13075-019-1839-5

Significance of anti-neutrophil cytoplasmic antibodies in systemic sclerosis

Internet

Similar Items